News from sponsors
‘Thea at Ten’ – 2018 brings a celebration of successes from the past decade at Thea Pharmaceuticals. With this comes a strong outlook toward continuing to grow as a company and deliver unparalleled preservative free eye care products that offer real benefits to patients.
To ensure that we continue this, we invest in education. Education is present in all areas of our ophthalmic business and in the production of our own educational resources. Therefore, Thea will be delivering four unique lectures during the impressive programme at Optometry Tomorrow, focusing on different aspects of eye health and the role of nutrition
Places are limited, please book your seat into these sessions
- Where and why should I give nutritional advice?
- Five reasons to look after eyelids
- Keeping patient’ adherent and the ocular surface happy in glaucoma.
- TFOS DEWS II: what does it mean to me?
Please visit the online programme to find out more detail about the content of each lecture.
We are also sponsoring a topical session in the main programme: New perspectives in diagnosing and managing dry eye: incorporating TFOS DEWS II in clinical practice by Professor James Wolffsohn from Aston University.
For more information on our products, training and literature packages please join us on the stand for a piece of celebratory piece of cake at our stand at the main entrance or visit our website www.thea-pharmaceuticals.co.uk
Platinum sponsors Topcon will be showcasing the following highlights on Stand 4:
- DRI OCT Triton and how OCT Angiography is applied in general optometric practice;
- 3D OCT-1 Maestro - the smallest automated 3D OCT with integrated colour fundus camera, which is exceptionally easy to use;
- Eye-Light® - latest in dry eye treatment, combining light modulation with optimal power energy and able to treat upper and lower eye lids simultaneously;
- SL-D701 LED Slit Lamp with digital camera for high quality still images, video and infrared Meibomian gland imaging;
- Henson 9000 for enhanced screening and monitoring of glaucoma with the unique ZATA threshold algorithm, which uses prior data for ongoing monitoring.
What’s more, Topcon’s much sought after optical biometry and topography system, Aladdin, will also be on display. Comprising of nine features: Axial Length; Keratometry; Anterior Chamber Depth; Central Corneal Thickness; Lens Thickness; Corneal Topography; Corneal Wave-front Analysis; Pupillometry and White-to-white analyses, in one unique instrument.
Topcon CET workshops:
- Nicholas Rumney will discuss intriguing cases from within primary care practice, such as choroidal folds and central serous retinopathy.
- Rebecca Stoner will lead a discussion on Dry Eye, its diagnosis and latest treatments.
- A hands on ‘Introduction to using Swept Source OCT’ will offer insight on its role within primary eye care.
Welcome to tomorrow.
The innovations of tomorrow, brought to you today.
Here at CooperVision we understand how important contact lenses are to people’s daily lives, recognise that every wearer is unique and appreciate the importance of crafting world-class lenses for both mainstream and challenging vision corrections. Our focus goes beyond product development to true innovation, tackling some of the greatest challenges of our time such as myopia management and the impact of the global transformation to a digital lifestyle.
CooperVision has brought new product innovations to the marketplace that work to meet the evolving needs of today’s wearers. Visit us at Optometry Tomorrow exhibition and conference to see them for yourself: MiSight® 1 day, the world’s first soft contact lens that is proven to reduce the progression of myopia in children1*, Biofinity Energys™, the contact lens specifically designed for today’s digital lives, and the latest addition to our daily disposable family, MyDay® toric.
* Compared with a standard single-vision, one-day lens over a three-year period
1. Chamberlain P, Back A, Lazon P, et al. 3-year effectiveness of a dual-focus 1 day soft contact lens for myopia control. Presented at the 40th British Contact Lens Association Clinical Conference and Exhibition; 10 June 2017; Liverpool, United Kingdom
Johnson & Johnson Vision is excited to bring – for the first time – its extended portfolio of products to Optometry Tomorrow 2018. With the acquisition of Abbot Medical Optics in 2017, Johnson & Johnson Vision welcomed the arrival of the consumer eye health portfolio, notably COMPLETE RevitaLens® MPDS and blink® eye care range of products. This allows you, our partners, to offer your patients a wider range of eye care products from the manufacturers of ACUVUE® - the world leader in contact lenses.1 Through you, we are able to serve more than 60 million patients a day across 103 countries, helping more people in more places improve or restore their sight.
Supporting further education for eye care professionals is key in making this commitment a reality. Johnson & Johnson Vision is delighted to bring you two interactive, multi-station discussion workshops: ‘Multifocal Contact Lenses – Getting it Right the First Time!’ and ‘Creating a Stable World for your Astigmats!’ With only a few spaces left be sure to book your space now to avoid disappointment.
We look forward to welcoming you at the Johnson & Johnson Vision stand at Optometry Tomorrow 2018 and showcasing our expanded portfolio. For more information on our services and products please visit our website www.jnjvisioncare.co.uk
OXYSEPT, OXYSEPT 1STEP, OXYSEPT COMFORT, LENSPLUS OCUPURE, Blink®, COMPLETE RevitaLens®, BLINK-N-CLEAN, BLINK CONTACTS, TOTALCARE, and ULTRAZYME are trademarks of Abbott Medical Optics Inc. ACUVUE® ACUVUE OASYS® and ACUVUE® VITA™ are trademarks of Johnson & Johnson Medical Ltd.
- Euromonitor International Limited; current process; fixed 2015 exchange rates; all channels, defined using standard Euromonitor definitions; 2014 retail value CL sales (rsp terms), defined using standard Euromonitor definitions. “Globally” and “World” defined as top 32 countries of 2014 CL retail value sales (rsp terms). Countries captures 91.3% 2014 CL retail value sales (rsp terms).
Optos’ vision is to be The Retina Company and recognized as a leading provider of devices to eye care professionals for improved patient care. Our core devices produce ultra-widefield, high resolution optomap images of approximately 82% or 200◦ of the retina, something no other device is capable of doing in a single capture.
Visit our stand or CET session to:
- Learn how optomap can help differentiate your business
- Learn how routine use of optomap can improve and increase patient throughput and potentially create an additional revenue stream
- Take advantage of a free, no obligation demo in your practice so you and your patients can experience the optomap 'WOW' factor.
- There are several financing options which make owning a new Daytona plus more affordable than ever.
Alcon’s® InContact digital platform connects opticians and contact lens wearers in the UK and Ireland.
InContact is a new e-commerce solution connecting contact lens wearers and optical businesses through the wearlenses.co.uk/wearlenses.ie websites. It enables opticians to set up personalised, digital storefronts and offer online ordering, home delivery, subscription programmes and open new digital communication channels to their patients.
“Year on year I try to find new ways of driving new fits into my four practices which I find a challenge as an independent. Now with InContact this gives me a new platform to drive new fits from an on-line perspective” said Mrs. Mani, Director of Coulsdon Opticians in Surrey, one of the first practices in the UK to adopt InContact.
“InContact has been developed for optical businesses to help build their practices, expand their online footprints, and create long-term relationships with contact lens wearers through improved after-care and customer management,” said Jan Wagner, Vision Care Franchise Head of Alcon Europe, Middle-East, Africa. “InContact reflects Alcon’s ongoing commitment to listen and respond to our customers’ needs”
For more information or to get involved please contact the InContact support line on 0371 376 0017 (UK), 0818 946 621 (ROI) or e-mail: firstname.lastname@example.org, or speak to us on our stand at Optometry Tomorrow 2018.
Medmont E300 Topographer, Comfort 15 Miniscleral, EyeDream Ortho-k... what do these three things have in common? Answer: They're all excellent tools for helping dry eye sufferers.
Available as standard with the Medmont E300 corneal topographer, the TFSQ (Tear Film Surface Analyser) module is a precision diagnostic tool for screening, measuring and monitoring tear film stability - perfect for demonstrating the effectiveness of a dry eye treatment or objectively displaying the superior wetting performance of a premium soft lens.
Beyond its onboard capabilities, the Memodnt E300 opens a host of contact lens related opportunities for patients suffering from dry eye.
EyeDream is an advanced ortho-k system that works exclusively corneal topography. As with all ortho-k, EyeDream lenses are worn overnight and removed in the morning, so for patients with dry eye who can’t tolerate soft lenses, EyeDream is the perfect choice.
Globally considered the ‘Gold Standard’ in topography, the Medmont E300 is a powerful instrument for screening corneal abnormalities. For many ECPs, the new go-to lens for a keratoconic patient is No7’s Comfort 15 miniscleral. Simple to fit and excellent value, Comfort 15 is a great choice for dry eye sufferers too as, being 15mm in diameter, it traps a tear reservoir behind the lens that soothes and protects the eye.
As part of the Scope portfolio we offer a full range of therapies to help manage MGD. OPTASE Moist Heat Mask is a reusable and soothing eye mask to help alleviate symptoms of MGD. 10-minutes of recommended Moist Heat Therapy will help loosen the oils in the glands. OPTASE TTO Lid Wipes are gentle and preservative free lid wipes for daily lid hygiene. Tea Tree Oil is naturally anti-bacterial and anti-inflammatory, and Hyaluronic Acid moisturises and soothes sore eyelids. Hycosan Dual eye lubricant for lipid deficient dry eye stabilises the tear film to reduce excessive evaporation. The Hycosan range of products are preservative free, contact lens compatible and sterile for 6 months.
Omega Eye contains very high levels of omega-3 fatty acids (1680mg EPA and 560mg DHA), offering a therapeutic dose in 4 capsules (or one 5ml spoonful of Omega Eye liquid) daily. This therapeutic dose helps to provide necessary anti-inflammatory benefits. BlephEx is an in-clinic procedure that allows health care practitioners to assist in the removal of excess bacteria, biofilm and bacterial toxins, the main causes of inflammatory dry eye and lid disease.
Master your data with ZEISS FORUM
Ideal for practices of any size, ZEISS FORUM is an intuitive software solution which allows you to integrate individual data sets into a single visualisation, helping to streamline your decision-making. In an age when we are producing increasing amounts of diagnostic data for analysis, optional modules Glaucoma Workplace and Retina Workplace allow you to efficiently assess all of the important information - at a glance.
ZEISS Glaucoma Workplace offers structure and function analysis at your fingertips. By combining functional data from visual fields tests and structural data from CIRRUS OCT exams into a single interactive report, this helps you to detect significant changes early which could have been missed when comparing results from multiple screens or reports. Users can also generate combined guided progression analysis reports, offering a progression summary to help you accurately assess the rate of which a patient is progressing.
ZEISS Retina Workplace is a fully interactive multimodality software solution that combines exam data from your OCT and fundus camera across three visits on one screen. With a click of a button, it offers quick visualization of macular pathology across multiple visits in a synchronized view, and brings certainty and efficiency in assessing and tracking change.
Learn more at www.zeiss.com/forum